Life Sciences Archive » July, 2007

Life Sciences - July, 2007

178 articles

• Dispute Over Drugs Hinders WTO Protocol
• Medical Device Maker Admits Guilt In FDA Case
• Tort Claimants Object To Solutia, Monsanto Pact
• Liability Claims Against Dexatrim Maker Dismissed
• States Fight Mediation In Drug Pricing Suit
• Avandia Survives Scrutiny From FDA Panel
• Scientists Lobby EU For New Stem Cell Rules
• J&J Settles Duragesic Suit For $2.5M
• Biomet Distributor, Exec Hit With Competition Suit
• Baxter Recalls Infusion Pumps
• FDA, Officials Hit With Suit Over Cancer Drug
• Citing Tellabs, Circuit Court Hands Baxter Victory
• AstraZeneca Chips Away At Seroquel Case
• Judge Extends Stay In Antitrust OxyContin Suit
• Caremark Repels Whistleblower Charges
• Nigeria Delays Suit Over Pfizer Clinical Trials
• CMS Creates Uncertainty With Proposed Changes
• Court OKs $36M Legal Bill In Bristol-Myers Suit
• The Dispositive Preemption Question
• Judge Says Abbott Can't Add Products To Suit
• Court Vacates Infringement Order Against Cordis
• Medtronic To Acquire Rival, Settle Spinal Patent Suit
• Aventis Triumphs In Patent Suit Over ALS Drug
• Serenex Sues Ex-Employee For Alleged Espionage
• Patent Board Challenges Federal Circuit To A Deuel
• Novartis's Zelnorm Enters Restricted Access Program
• Judge Pushes New Vioxx Cases Forward
• Asbestos-Related Claims Diluted For Voting On Plan
• In Landmark Case, Federal Circuit Finds For Merck
• Judge Orders Mediation In Drug Pricing Suit
• Boston Scientific Jumps Into Medtronic's Patent Case
• Ranbaxy, Glaxo Bury Hatchet Over Valtrex
• Judge Tentatively Dismisses Ditropan Complaint
• Nanotechnology Stays Off Label: FDA Report
• Cardinal Health Settles With SEC For $35 Million
• Stay Approved In Bone-Fusing Staple Patent Dispute
• Master Rejects Bextra Plaintiffs' Discovery Request
• Sanofi Mounts Offensive For Eloxatin
• Spanish Court Upholds Lipitor Patent
• Roche, Bayer Present New Evidence Against Abbott
• Propulsid Suits Dismissed As Case Draws To A Close
• Glaxo Sales Drop As FDA Hearings Approach
• FTC, DOJ Merger Reviews Up Slightly This Year
• States Bury Hatchet With TAP Over Drug Pricing
• Patent Group Moves From Greenberg Traurig To Dreier
• Judge Allows Pharmanet Derivative Suit To Continue
• The BPAI Returns To Graham V. John Deere
• Federal Circuit Affirms Invalidity Of Toprol Patents
• Schering Sues Barr Over Brain Tumor Drug
• Jewish Mother Wins Discrimination Suit Against VA
• Zyprexa Plaintiff Wants To Go It Alone Against Eli Lilly
• Bausch & Lomb, CIBA Sued Over Contact Lens Patent
• Avon Plaintiffs Fight Application of Tellabs
• Schulte Roth & Zabel Adds To Employment Group
• Ephedra Still Causing Headaches For Diet Pill Makers
• Plaintiffs Accuse Novartis Of Violating Court Order
• Experts Rebutted In Pfizer's Celebrex Case
• Court Throws Out Gen-Probe's HPV License Suit
• Ortho-McNeil Sues Apotex Over Ultracet Patent
• Mayne Renews Crusade For Colon Cancer Drug
• Judge Tosses Some Accutane IBD Cases
• Federal Circuit Nixes Nucleonics' Patent Dispute
• Abbott Gets Third-Party Subpoenas Quashed
• Appeals Court Keeps Merck Derivative Suit Alive
• Pfizer Faces Class Action Over Employee Data Leak
• Wilson Sonsini Hit With Suit Over Missing Certificates
• Drug Exec, Son Sentenced To Jail For Insider Trading
• Nigeria To File New Version Of Lawsuit Against Pfizer
• Medtronic, Attys. Drain Defibrillator Plaintiff Pool
• Abbott Aims To Quash Bayer Subpoena
• House Bill Would Stifle FDA's Plan To Close Labs
• Bristol-Myers Pays $13M To Settle Pricing Class Action
• Drug Makers Seek Dismissal Of Wholesale Price Suit
• Assistant AG Joins Fulbright's Healthcare Practice
• Purdue Wins Appeal In OxyContin Liability Suit
• Court Revives Health Sciences Cos. Merger Dispute
• Par, Ortho-McNeil Settle Ultracet Patent Spat
• Roche, Bayer Press Abbott To Turn Over Patent Deal
• Impax Appeals Prilosec Case To Federal Circuit
• Abbott Bids To Toss New Government Claims
• Patent Appeals Board Ditches TSM For Stricter Tests
• Cypress Returns Fire Against Glaxo Over Zantac
• Aredia Product-Liability Plaintiffs Amend Complaints
• Ex-King Pharmaceutical Employee Loses Bid For Fees
• Novartis Chastised For Litigation Delay
• YouTube Helps Solicit Participants For Paxil Payback
• Special Master OKs $70M Glaxo Settlement
• Learned Intermediary Doctrine: Required By Law?
• World Bank Bars Indian Drug Firms For Price-Fixing
• Technicians Hit CVS With FLSA Suit
• Novo Nordisk Takes On Sanofi Over Insulin Pens
• Judge OKs Dismissal Of Some Ephedra Claims
• Abbott, Andrx Settle Biaxin XL Litigation
• EMEA Issues Guidance On Biosimilar Drugs
• Solutia May Face More Damages Over Nitro Plant
• Ephedra Judge Limits Doctor's Expert Testimony
• Appeals Court Revives HP Whistleblower Suit
• Sepracor, Barr Clash Over Asthma Drug
• Boston Scientific Pays $195M To Bury Defibrillator MDL
• Taro Shareholders Defend Securities Fraud Complaint
• Alza, Ortho-McNeil Bid To Toss Ditropan Claims
• Trying A Patent Validity Case In A Post-KSR World
• Court Reopens Teva, Novartis Spat Over Herpes Drug
• Cipro Antitrust Case Goes To State Court
• Roche Expects IBD Suits' Dismissal In Accutane MDL
• Zyprexa Suits Weigh Heavily On Eli Lilly's Future
• Boston Scientific Fights To Fire Subsidiary's Execs
• Viagra Case Focuses On Evidence Of Causation
• As Court Battle Rages, Pfizer's Celebrex Sales Soar
• Xyrem Settlement Gets Green Light
• Walgreens Pays $20M To Settle With EEOC
• Medtronic May Have To Rethink Defense
• Patent Litigation: Is The Party Over?
• N.Y. Slams Drug Makers' Calls To Toss AWP Case
• Plaintiffs Point To "Tellabs" In Pfizer Securities Suit
• Boehringer Sues Barr Over Generic Stroke Drug
• House Gives Go Ahead To Drug Bill, Hurdles Remain
• Conflict Escalates Between Pharma, Bank
• Judge Allows Aredia Plaintiffs To Alter Complaint
• Apotex Wins Appelate Reversal In Ofloxacin Case
• Medtronic Hit With Catheter Patent Suit
• Accutane Plaintiffs Win Bid To Shield Docs
• Boston Scientific Seeks To Intervene In Medtronic Case
• Appeals Court Clears J&J In Remicade Suit
• Celebrex, Bextra Claims Withstand Judge's Scrutiny
• Pozen Settles Securities Class Action
• Purdue Pharma Denies KV's Antitrust Allegations
• SEC Looks Into Dendreon Following FDA Disclosure
• QLT Faces $70M Bill From Visudyne Ruling
• As Defibrillator Trial Approaches, Guidant Falters
• Merck Punches Back In Fosamax Case
• Solutia Tackles Objections In New Plan, Statement
• Ephedra Plaintiff Fights Herbalife's Bid To Bar Info
• AstraZeneca, Bristol-Myers Oppose "Do Over"
• Pfizer Gains Victory In Irish Lipitor Case
• Mylan ANDA Sparks Another Effexor Suit
• Plaintiff Attempts To Send Guidant Case To State Court
• Plaintiffs' Expert Testimony Struck From Baycol Case
• Nellson, Creditors Move To End Examination
• PharmaStem Blood Storage Patents Not Valid: Judge
• Judge Nixes Settlement Master In Seroquel Suit
• Matsushita and MediaTek Settle All Patent Disputes
• Patient Asks Judge To Rethink Crestor Ruling
• Catheter Maker Claims Rivals Spread False Rumors
• Abbott Fails In Effort To End Pregnancy Test Case
• Asbestos Victims Attack Pfizer Over Bankruptcy Plan
• Seroquel Plaintiffs Agree To Dismiss 14 Of Their Own
• Ex-Cardinal Health Execs Settle Derivative Suits
• Plaintiffs Call For Guidant To Turn Over Device Data
• Wholesale Price Plaintiffs Call Damages Incomplete
• Judge Hands Pfizer A Mixed Bag In Celebrex Case
• Google, Yahoo Face Heat Over Online Ad Programs
• MWE Appoints New Head Of Italian Competition Group
• Prempro Judge OKs Case-Specific Discovery
• Judge Approves Ramp Corp. Settlement
• AstraZeneca Faces Call For Sanctions
• Herbalife Seeks To Bar Ephedra Data
• SonoSite Claims GE Infringed Ultrasound Patents
• Pfizer Sued Over Hormone Replacement Drugs
• Label Doesn't Clear Merck From Vioxx Liability: Judge
• SSRIs, Suicide Link Takes Center Stage In Forest Suits
• Study Could Weaken Merck's Vioxx Defense: Report
• FDA Toughens Dietary Supplements Guidelines
• FDA Pens Deal With EU Over Food Safety
• No Zyprexa Negotiator In Seroquel Case: AstraZeneca
• CVS, Ex-Execs Settle Earnings Misstatement Claims
• FCPA: High Risks For The Medical Device Industry
• ITC To Review Ink Cartridge Ruling
• Drug Makers Settle Suit Over Epilepsy Treatment
• Guidant Fights Plaintiffs' Bid For Sanctions
• Lilly Suffers Setback In Zyprexa Suit
• Judge Greenlights Becton Dickinson Antitrust Suit
• Judge Sides With J&J in Defective Sutures Suit
• Wyeth Fights Plaintiffs' Bid For Prempro Docs
• ICU Medical Smacked With $4.75M Fee
• Rite Aid Moves to Block Arbitration With Union
• EC Calls For Nestle To Divest In Novartis Union
• Court Deals Blow To Mylan In Norvasc Dispute